Journal of Surgical Research
Volume 145, Issue 2 , Pages 214-222, April 2008

Silymarin, the Antioxidant Component of Silybum marianum, Prevents Sepsis-Induced Acute Lung and Brain Injury

  • Hale Z. Toklu, Ph.D.

      Affiliations

    • Department of Pharmacology, School of Pharmacy, Marmara University
  • ,
  • Tugba Tunali Akbay, Ph.D.

      Affiliations

    • Department of Biochemistry, School of Dentistry, Istanbul, Turkey
  • ,
  • Ayliz Velioglu-Ogunc, Ph.D.

      Affiliations

    • Vocational School of Health Related Professions, Istanbul, Turkey
  • ,
  • Feriha Ercan, Ph.D.

      Affiliations

    • Department of Histology-Embryology, School of Medicine, Istanbul, Turkey
  • ,
  • Nursal Gedik, M.D.

      Affiliations

    • Department of Kasimpasa Military Hospital, Division of Biochemistry, Istanbul, Turkey
  • ,
  • Meral Keyer-Uysal, Ph.D.

      Affiliations

    • Department of Pharmacology, School of Pharmacy, Marmara University
  • ,
  • Goksel Sener, Ph.D.

      Affiliations

    • Department of Pharmacology, School of Pharmacy, Marmara University
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Marmara University, School of Pharmacy, Tıbbiye Cad. 34668 İstanbul, Turkey.

Received 12 December 2006 published online 22 October 2007.

Background

Sepsis is associated with enhanced generation of reactive oxygen species, which leads to multiple organ dysfunctions. Based on the potent antioxidant effects of silymarin, we investigated the putative protective role of silymarin against sepsis-induced oxidative damage in lung and brain tissues.

Materials and methods

Sepsis was induced by cecal ligation and perforation (CLP). Sham and CLP groups received either vehicle or silymarin (50 mg/kg, p.o.) or 150 mg/kg i.p. N-acetylcysteine (NAC) for 10 days prior and immediately after the operation. Six hours after the surgery, rats were decapitated and blood was collected for the measurement of proinflammatory cytokines (tumor necrosis factor-alpha, interleukin-1β [IL-1β], and IL-6) levels, lactate dehydrogenase activity, and total antioxidant capacity. Lung and brain samples were taken for the measurement of malondialdehyde and glutathione levels, myeloperoxidase activity, thromboplastic activity, and also for histological assessment. Formation of reactive oxygen species in tissue samples was monitored by using chemiluminescence technique with luminol and lusigenin probe.

Results

Sepsis increased serum TNF-α, IL-1β, IL-6 levels, and lactate dehydrogenase activity and decreased total antioxidant capacity. On the other hand, tissue glutathione levels were decreased while malondialdehyde levels and myeloperoxidase activity were increased in both the lung and the brain tissues due to CLP. Furthermore, luminol and lucigenin chemiluminescence were significantly increased in the CLP group, indicating the presence of the oxidative damage. Silymarine and NAC treatment reversed these biochemical parameters and preserved tissue morphology as evidenced by histological evaluation.

Conclusions

Silymarin, like NAC, reduced sepsis-induced remote organ injury, at least in part, through its ability to balance oxidant–antioxidant status, to inhibit neutrophil infiltration, and to regulate the release of inflammatory mediators.

Key Words: Silybum marianum, silymarin, sepsis, antioxidant, cytokine, myeloperoxidase, glutathione, N-acetylcysteine, lung, brain

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0022-4804(07)00237-5

doi:10.1016/j.jss.2007.03.072

Journal of Surgical Research
Volume 145, Issue 2 , Pages 214-222, April 2008